These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 6408406)
1. Studies of the type A and type B monoamine oxidase. A new approach to their development and subcellular localization. Yu PH; Hertz L Mod Probl Pharmacopsychiatry; 1983; 19():177-88. PubMed ID: 6408406 [No Abstract] [Full Text] [Related]
2. Studies on the subcellular localization of monoamine oxidase types A and B and its importance for the deamination of dopamine in the rat brain. Urwyler S; von Wartburg JP Biochem Pharmacol; 1980 Nov; 29(22):3067-73. PubMed ID: 6779822 [No Abstract] [Full Text] [Related]
3. Subcellular localization of types A and B monoamine oxidase in rat brain. Student AK; Edwards DJ Biochem Pharmacol; 1977 Dec; 26(24):2337-42. PubMed ID: 597322 [No Abstract] [Full Text] [Related]
4. Neuropharmacological studies on selective monoamine oxidase A and B inhibitors. Mukhopadhyay M; Upadhyay SN; Bhattacharya SK Indian J Exp Biol; 1987 Nov; 25(11):761-70. PubMed ID: 3133314 [No Abstract] [Full Text] [Related]
5. Inactivation of cytochrome P4502B1 by the monoamine oxidase inhibitors R-(-)-deprenyl and clorgyline. Sharma U; Roberts ES; Hollenberg PF Drug Metab Dispos; 1996 Jun; 24(6):669-75. PubMed ID: 8781784 [TBL] [Abstract][Full Text] [Related]
6. Age-dependent effects of the 2'-methyl analog of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine: prevention by inhibitors of monoamine oxidase B. Finnegan KT; Irwin I; Delanney LE; Langston JW J Pharmacol Exp Ther; 1995 May; 273(2):716-20. PubMed ID: 7752075 [TBL] [Abstract][Full Text] [Related]
7. [A behavioral and neurochemical study on the mechanism of the anxiolytic effect of monoamine oxidase inhibitors]. Maki Y Hokkaido Igaku Zasshi; 2001 May; 76(3):133-42. PubMed ID: 11481866 [TBL] [Abstract][Full Text] [Related]
8. Proceedings: Monoamine oxidase from rat reticulocytes: subcellular localization of the enzyme activity and effects of irreversible non-hydrazine inhibitors. Quiring K; Hubertus S Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R83. PubMed ID: 1143505 [No Abstract] [Full Text] [Related]
9. Localization of catecholamine degrading enzymes in the rat heart. Lowe MC; Creveling CR Proc West Pharmacol Soc; 1978; 21():473-4. PubMed ID: 693535 [No Abstract] [Full Text] [Related]
10. Enhancement of striatal lipid peroxidation induced by 1-methyl-4-phenylpyridinium in mouse brain is blocked by MAO-B inhibitors. Ríos C; Bravo-Velazquez S; Altagracia M; Kravzov J Proc West Pharmacol Soc; 1994; 37():159-60. PubMed ID: 7984654 [No Abstract] [Full Text] [Related]
11. Inhibition of methamphetamine-induced hyperlocomotion in mice by clorgyline, a monoamine oxidase-a inhibitor, through alteration of the 5-hydroxytriptamine turnover in the striatum. Kitanaka N; Kitanaka J; Takemura M Neuroscience; 2005; 130(2):295-308. PubMed ID: 15664686 [TBL] [Abstract][Full Text] [Related]
12. Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridinyl derivatives. Inoue H; Castagnoli K; Van Der Schyf C; Mabic S; Igarashi K; Castagnoli N J Pharmacol Exp Ther; 1999 Nov; 291(2):856-64. PubMed ID: 10525109 [TBL] [Abstract][Full Text] [Related]
13. (-)-Trans-epsilon-viniferin, a polyphenol present in wines, is an inhibitor of noradrenaline and 5-hydroxytryptamine uptake and of monoamine oxidase activity. Yáñez M; Fraiz N; Cano E; Orallo F Eur J Pharmacol; 2006 Aug; 542(1-3):54-60. PubMed ID: 16828740 [TBL] [Abstract][Full Text] [Related]
14. High-throughput screening for monoamine oxidase-A and monoamine oxidase-B inhibitors using one-step fluorescence assay. Guang HM; Du GH Acta Pharmacol Sin; 2006 Jun; 27(6):760-6. PubMed ID: 16723097 [TBL] [Abstract][Full Text] [Related]
15. Striatal 6-[18F]fluorodopa accumulation after combined inhibition of peripheral catechol-O-methyltransferase and monoamine oxidase type B: differing response in relation to presynaptic dopaminergic dysfunction. Ruottinen HM; Rinne JO; Oikonen VJ; Bergman JR; Haaparanta MT; Solin OH; Ruotsalainen UH; Rinne UK Synapse; 1997 Dec; 27(4):336-46. PubMed ID: 9372556 [TBL] [Abstract][Full Text] [Related]
16. Monoamine oxidase and catechol-O-methyltransferase activities in cultured human skin fibroblasts. Roth JA; Breakefield XO; Castiglione CM Life Sci; 1976 Dec; 19(11):1705-10. PubMed ID: 1004130 [No Abstract] [Full Text] [Related]
17. 2'-NH2-MPTP in Swiss Webster mice: evidence for long-term (6-month) depletions in cortical and hippocampal serotonin and norepinephrine, differential protection by selective uptake inhibitors or clorgyline and functional changes in central serotonin neurotransmission. Andrews AM; Murphy DL J Pharmacol Exp Ther; 1993 Dec; 267(3):1432-9. PubMed ID: 8263805 [TBL] [Abstract][Full Text] [Related]
18. [Study of the tissue and subcellular distribution of isatin-binding proteins with optical biosensor]. Ivanov IuD; Panova NG; Gnedenko OV; Buneeva OA; Medvedev AE; Archakov AI Vopr Med Khim; 2002; 48(1):73-83. PubMed ID: 12068500 [TBL] [Abstract][Full Text] [Related]
19. Modification of dopamine release by selective inhibitors of MAO-B. Finberg JP; Lamensdorf I; Armoni T Neurobiology (Bp); 2000; 8(2):137-42. PubMed ID: 11061211 [TBL] [Abstract][Full Text] [Related]
20. [Interactions between monoaminergic neurons projecting to the cerebral cortex]. Descarries L; Ferron A; Reader TA; de Montigny C Union Med Can; 1985 Dec; 114(12):964-8, 973. PubMed ID: 3938097 [No Abstract] [Full Text] [Related] [Next] [New Search]